Schulze-Neick I[au] - Search Results

Year	Number of Results
1992	3
1993	4
1994	2
1995	1
1996	1
1997	3
1998	2
1999	2
2000	5
2001	1
2002	1
2003	3
2004	8
2005	5
2006	5
2007	2
2008	2
2009	3
2010	7
2011	4
2012	5
2013	4
2014	2
2015	2
2016	4
2017	3
2018	1
2019	3
2020	1
2022	0

1

Pediatric pulmonary hypertension.

Ivy DD, Abman SH, Barst RJ, Berger RM, Bonnet D, Fleming TR, Haworth SG, Raj JU, Rosenzweig EB, Schulze Neick I, Steinhorn RH, Beghetti M. Ivy DD, et al. Among authors: schulze neick i. J Am Coll Cardiol. 2013 Dec 24;62(25 Suppl):D117-26. doi: 10.1016/j.jacc.2013.10.028. J Am Coll Cardiol. 2013. PMID: 24355636 Free article. Review.

2

Classifying pulmonary hypertension in the setting of the congenitally malformed heart--cleaning up a dog's dinner.

Schulze-Neick I, Beghetti M. Schulze-Neick I, et al. Cardiol Young. 2008 Feb;18(1):22-5. doi: 10.1017/S1047951107001850. Epub 2008 Jan 15. Cardiol Young. 2008. PMID: 18197998 Free article. Review. No abstract available.

3

The Creation of an Interatrial Right-To-Left Shunt in Patients with Severe, Irreversible Pulmonary Hypertension: Rationale, Devices, Outcomes.

Lehner A, Schulze-Neick I, Fischer M, Fernandez-Rodriguez S, Ulrich S, Haas NA, Jakob A. Lehner A, et al. Among authors: schulze neick i. Curr Cardiol Rep. 2019 Mar 18;21(5):31. doi: 10.1007/s11886-019-1118-8. Curr Cardiol Rep. 2019. PMID: 30887235 Review.

4

[Pulmonary hypertension and pulmonary circulation in congenital heart disease].

Schulze-Neick I, Kaemmerer H. Schulze-Neick I, et al. Dtsch Med Wochenschr. 2009 Aug;134 Suppl 5:S170-2. doi: 10.1055/s-0029-1225317. Epub 2009 Aug 28. Dtsch Med Wochenschr. 2009. PMID: 19718608 Review. German.

5

Modulation of pulmonary vascular resistance as a target for therapeutic interventions in Fontan patients: focus on phosphodiesterase inhibitors.

Ciliberti P, Schulze-Neick I, Giardini A. Ciliberti P, et al. Among authors: schulze neick i. Future Cardiol. 2012 Mar;8(2):271-84. doi: 10.2217/fca.12.16. Future Cardiol. 2012. PMID: 22413985 Review.

6

[Pharmacological treatment of pulmonary hypertension in patients with congenital heart disease].

Miera O, Farahwaschy B, Schulze-Neick I, Berger F. Miera O, et al. Among authors: schulze neick i. Dtsch Med Wochenschr. 2008 Oct;133 Suppl 6:S209-11. doi: 10.1055/s-0028-1091241. Epub 2008 Sep 23. Dtsch Med Wochenschr. 2008. PMID: 18814099 Review. German.

7

[Pulmonary hypertension in congenital heart disease].

Schulze-Neick I. Schulze-Neick I. Dtsch Med Wochenschr. 2006 Dec 8;131(49 Suppl 9):S322-4. doi: 10.1055/s-2006-957202. Dtsch Med Wochenschr. 2006. PMID: 17139597 Review. German.

8

The risk of infective endocarditis following interventional pulmonary valve implantation: A meta-analysis.

Lehner A, Haas NA, Dietl M, Jakob A, Schulze-Neick I, Dalla Pozza R, Rodriguez SF, Fischer M. Lehner A, et al. Among authors: schulze neick i. J Cardiol. 2019 Sep;74(3):197-205. doi: 10.1016/j.jjcc.2019.04.007. Epub 2019 May 18. J Cardiol. 2019. PMID: 31113702 Free article.

9

Issues related to the management and therapy of paediatric pulmonary hypertension.

Schulze-Neick I, Beghetti M. Schulze-Neick I, et al. Eur Respir Rev. 2010 Dec;19(118):331-9. doi: 10.1183/09059180.00008510. Eur Respir Rev. 2010. PMID: 21119192 Free article. Review.

10

Motor outcome, executive functioning, and health-related quality of life of children, adolescents, and young adults after ventricular assist device and heart transplantation.

Barron LC, Haas N, Hagl C, Schulze-Neick I, Ulrich S, Lehner A, Heinen F, Weinberger R, Rosenthal L, Gerstl L, Dalla-Pozza R. Barron LC, et al. Among authors: schulze neick i. Pediatr Transplant. 2020 Feb;24(1):e13631. doi: 10.1111/petr.13631. Epub 2019 Dec 29. Pediatr Transplant. 2020. PMID: 31885156

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results